AURORA, Colo., Feb. 1 The Colorado Institute for Drug, Device and Diagnostic Development (CID4) launches this month with a statewide "Call for Proposals" from Colorado life science technologies in need of funding and active management. The announcement is made by Kevin M. Smith, CID4 Executive Vice President/COO and spokesperson.
"With more than 20,000 good-paying jobs in Colorado, the life sciences industry is one of our state's most important economic sectors today and it holds incredible promise for tomorrow," Colorado Gov. Bill Ritter said.
CID4 was formed through the collaborative efforts of all sectors of the Colorado Life Science community to bridge the gap between basic research and successful product commercialization, thereby creating more Colorado jobs in the life science industry.
"We are very excited about this opportunity to continue developing Colorado's life science sector. With initial financial support in the form of grants from the State of Colorado and Fitzsimons Redevelopment Authority, we have been able to commence operations, recruit a highly distinguished Technical and Business Advisory Committee and reach out to sources of technology across the State," Richard C. Duke, CID4 President & CEO, explains.
"By helping promising technologies in need of startup assistance to become great companies, CID4 becomes our secret weapon to growing more, higher-paying Colorado jobs" The Honorable Ed Tauer, Mayor of the City of Aurora says.
About the First Solicitation
CID4 invites Colorado-based Technology Transfer Offices (TTOs), researchers and inventors from Colorado-based public and private not-for-profit research Institutions, independent researchers and inventors in Colorado, and private Colorado-based Life Science Companies to submit technologies for consideration. For deadline information and submission form, visit: http://www.cid4.com/downloads/CID4_technology_012710.pdf
About The Colorado Institute for Drug, Device and Diagnostic Development
CID4 is transforming life science innovation into commercial success by identifying and funding potential opportunities, and utilizing the talents of an advanced leadership team to ensure ultimate market value. For more information, visit http://www.cid4.com.
SOURCE The Colorado Institute for Drug, Device and Diagnostic Development